Oslo
Norway
AstraZeneca Pharmaceuticals - Cardiovascular, Renal and Metabolism
Chronic kidney disease, renal impairment, prevalence, epidemiology, outcomes, costs, primary care, public health, global health
Heart failure, Renal failure, COVID-19, Influenza, Prognosis